Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A paraneoplastic syndrome that involves the nervous system.
Biomarker and diagnostic research for paraneoplastic neurologic syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for paraneoplastic neurologic syndrome.
159 publications have been identified in PubMed for paraneoplastic neurologic syndrome. Kisho has analyzed 112 by research type. Research spans Review / Meta-Analysis (43%), Case Report / Case Series (24%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 48 | 43% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:56 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies |
27 |
24% |
Laboratory research | 17 | 15% |
Clinical study results | 8 | 7% |
Testing and diagnosis research | 5 | 4% |
Disease patterns and progression | 5 | 4% |
New treatment approaches | 2 | 2% |
Tirthani E (2026). [PMID: 33232100](https://pubmed.ncbi.nlm.nih.gov/33232100/). *Unknown Journal*. [Case Report / Case Series]
Olivé-Cirera G (2026). [PMID: 41499722](https://pubmed.ncbi.nlm.nih.gov/41499722/). *Neurol Neuroimmunol Neuroinflamm*. [Basic Science / Preclinical]
Guerin JB (2026). [PMID: 41932776](https://pubmed.ncbi.nlm.nih.gov/41932776/). *Neuroimaging Clin N Am*. [Review / Meta-Analysis]
Pruitt AA (2026). [PMID: 41631921](https://pubmed.ncbi.nlm.nih.gov/41631921/). *Continuum (Minneap Minn)*. [Review / Meta-Analysis]
Aly R (2026). [PMID: 32809473](https://pubmed.ncbi.nlm.nih.gov/32809473/). *Unknown Journal*. [Case Report / Case Series]
Masood W (2026). [PMID: 29939664](https://pubmed.ncbi.nlm.nih.gov/29939664/). *Unknown Journal*. [Case Report / Case Series]
Yogeshwar SM (2026). [PMID: 40650880](https://pubmed.ncbi.nlm.nih.gov/40650880/). *Brain*. [Case Report / Case Series]
Margolin E (2026). [PMID: 33232023](https://pubmed.ncbi.nlm.nih.gov/33232023/). *Unknown Journal*. [Case Report / Case Series]
Jin M (2026). [PMID: 42214057](https://pubmed.ncbi.nlm.nih.gov/42214057/). *Neurol Neuroimmunol Neuroinflamm*. [Epidemiology / Natural History]
Sposato A (2026). [PMID: 41591248](https://pubmed.ncbi.nlm.nih.gov/41591248/). *Radiology*. [Case Report / Case Series]
AI-curated news mentioning paraneoplastic neurologic syndrome
Updated Jun 12, 2026
A case report highlights the diagnostic challenges of paraneoplastic neurologic syndrome in a patient with advanced lung cancer exhibiting mixed adenocarcinoma and squamous features. This study underscores the complexities in identifying paraneoplastic syndromes associated with lung cancer.
Recent research highlights that motor neuron disease may manifest as a paraneoplastic neurologic syndrome, showcasing diverse phenotypes. This discovery could influence diagnostic approaches and treatment strategies for affected patients.
A recent study highlights a case of Epstein-Barr virus-positive diffuse large B-cell lymphoma presenting as pyrexia of unknown origin, complicated by paraneoplastic neurological syndrome. This research adds to the understanding of the complex interactions between viral infections and lymphoproliferative disorders.